1. Home
  2. LGND vs CSTM Comparison

LGND vs CSTM Comparison

Compare LGND & CSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • CSTM
  • Stock Information
  • Founded
  • LGND 1987
  • CSTM 2010
  • Country
  • LGND United States
  • CSTM France
  • Employees
  • LGND 68
  • CSTM N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • CSTM Metal Fabrications
  • Sector
  • LGND Health Care
  • CSTM Industrials
  • Exchange
  • LGND Nasdaq
  • CSTM Nasdaq
  • Market Cap
  • LGND 2.2B
  • CSTM 1.9B
  • IPO Year
  • LGND 1992
  • CSTM 2013
  • Fundamental
  • Price
  • LGND $139.02
  • CSTM $13.66
  • Analyst Decision
  • LGND Strong Buy
  • CSTM Buy
  • Analyst Count
  • LGND 8
  • CSTM 3
  • Target Price
  • LGND $144.71
  • CSTM $18.00
  • AVG Volume (30 Days)
  • LGND 139.7K
  • CSTM 1.5M
  • Earning Date
  • LGND 08-05-2025
  • CSTM 07-29-2025
  • Dividend Yield
  • LGND N/A
  • CSTM N/A
  • EPS Growth
  • LGND N/A
  • CSTM N/A
  • EPS
  • LGND N/A
  • CSTM 0.50
  • Revenue
  • LGND $181,488,000.00
  • CSTM $7,434,000,000.00
  • Revenue This Year
  • LGND $18.41
  • CSTM $3.76
  • Revenue Next Year
  • LGND $18.87
  • CSTM $12.00
  • P/E Ratio
  • LGND N/A
  • CSTM $27.61
  • Revenue Growth
  • LGND 53.40
  • CSTM N/A
  • 52 Week Low
  • LGND $81.74
  • CSTM $7.33
  • 52 Week High
  • LGND $129.90
  • CSTM $19.53
  • Technical
  • Relative Strength Index (RSI)
  • LGND 75.81
  • CSTM 53.75
  • Support Level
  • LGND $120.68
  • CSTM $13.28
  • Resistance Level
  • LGND $126.24
  • CSTM $14.71
  • Average True Range (ATR)
  • LGND 4.48
  • CSTM 0.43
  • MACD
  • LGND 1.87
  • CSTM -0.12
  • Stochastic Oscillator
  • LGND 96.06
  • CSTM 37.58

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About CSTM Constellium SE (France)

Constellium SE is engaged in the design and manufacture of rolled and extruded aluminium products, serving the packaging, aerospace, automotive, defence and other transportation and industry end-markets. The business is organized into three operating segments: the Packaging and Automotive Rolled Products segment which includes the production of rolled aluminium sheet products in European and North American facilities; the Aerospace and Transportation segment includes the production of rolled aluminium products and very limited volumes of extruded products in European and North American facilities; the Automotive Structures and Industry segment includes the production of extruded aluminium products and aluminium structural components.

Share on Social Networks: